期刊文献+

PTD介导的蛋白转导技术及其在医学领域中的应用 被引量:2

PTD Mediated Protein Transduction Technology and Its Application in Medical Field
原文传递
导出
摘要 生物活性的大分子物质导入细胞内部,能够最直接有效地改变细胞的状态,因而具有巨大的潜在医药价值。但是一直以来,如何将具有生物活性的大分子物质导入细胞内部始终困扰着人们,蛋白质转导域(PTD)介导的蛋白转导技术解决了这一难题。其高效的转导功能为疾病的临床治疗、治疗性蛋白药物的开发、基础医学和应用医学等领域的研究开辟了一条崭新的途径。人们已经成功地应用这一技术将多种物质导入细胞或机体的组织器官,显示了其优越的应用价值。 The delivery of bioactive macromolecular substances into cells provides an efficient approach to changing cellular conditions,and is thus of enormously potential therapeutic significance.It has also been an extremely difficult approach due the the impediment and protective nature of cell membrance until the protein transduction domain's(PTD's) capability to ferry macromolecule across cell membrance was discovered.PTD's efficient transductive function has rendered an exciting promise to the clinical treatment of diseases,therapeutic proteins drug development,and basic medical and applied research.The technology has been successfully applied to deliver a variety of substances into cells or tissue organs,and its superior application values have been explicitly demonstrated.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2011年第2期401-404,共4页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30800258) 福州大学科技发展基金资助项目(2008-XY-17)
关键词 蛋白转导技术 蛋白质转导域 机制 应用 Protein transduction technology Protein transduction domain(PTD) Mechanism Application
  • 相关文献

参考文献3

二级参考文献6

共引文献9

同被引文献20

  • 1Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein trailsduction into mammalian cells. Methods, 2001, 24: 247-256.
  • 2Ho A, Schwarze SR, Mermelstein SJ, et al. Synthetic protein transductian domains: enhanced transduction potential in vitro and in vivo. Cancer Res, 2001, 61: 474-477.
  • 3Lewin M, Carelesso N, Tung CH, et al. TAT peptide-derivatized magnetic nanoparticles allow in vivo tracking recovery of progenitorcells. Nat Biotechnol, 2000, 18: 410.
  • 4Torchilin VP, Levchenko TS. TAT-liposomes: a novel intracellular drug carrier. Curr Protein Pept Sci, 2003: 4133-4140.
  • 5Tseng YL, Liu JJ, Hong RL, et al. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol Pharmacol, 2002, 62: 864-872.
  • 6Umezawa N, Gelman MA, Haigis MC, et al. Translocation of a beta- peptide across cell membranes. J Am Chem Soc, 2002, 124: 368-369.
  • 7Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intraeellular protein delivery. J Biol Chem, 2001, 276: 5836-5840.
  • 8CraigieD.Caseofdiseaseandenlargementofthespleeninwhichdeathtookplacefromthepresenceofpurulentmatterintheblood[J].EdinbMedSurgJ,1845,64:400-413.
  • 9ZhangX,WongR,HaoSX,etal.TheSH2domainofbcr/Ablisnotrequiredtoinduceamurinemyeloproliferativedisease;however,SH2signalinginfluencesdiseaselatencyandphenotype[J].Blood,2001,97(1):277-287.
  • 10UnderhillDayN,PierceS,ThompsonSE,etal.RoleoftheCterminalactinbindingdomaininBCR/ABLmediatedsurvivalanddrugresistance[J].BrJHaematol,2006,132(6):774-783.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部